Cobas HPV Test for First-Line Screening for Cervical Cancer

Journal of Community and Supportive Oncology - United States
doi 10.12788/jcso.0039
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontline Medical Communications, Inc.

Related search

Clinical Validation of the Cobas HPV Test on the Cobas 6800 System for the Purpose of Cervical Screening

Journal of Clinical Microbiology
Microbiology
2018English

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the Cobas HPV Test

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2015English

HPV Screening for Cervical Cancer in Rural India

New England Journal of Medicine
Medicine
2009English

A Circulating miRNA Assay as a First-Line Test for Prostate Cancer Screening

British Journal of Cancer
Cancer ResearchOncology
2016English

Cervical Cancer: Applications of Genotyping for the Screening in Human Papilomavirus (HPV)

2018English

Clinical Performance of Roche Cobas 4800 HPV Test

Journal of Clinical Microbiology
Microbiology
2014English

Clinical Validation of the HPVIR High-Risk HPV Test on Cervical Samples According to the International Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Cancer Screening

Virology Journal
VirologyInfectious Diseases
2019English

Clinical Evaluation and Budget Impact Analysis of Cervical Cancer Screening Using Cobas 4800 HPV Screening Technology in the Public Sector of South Africa

PLoS ONE
Multidisciplinary
2019English

Screening for Cervical Cancer

JAMA - Journal of the American Medical Association
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy